Recent Finacing
Recent Raise
Genvax Technologies develops RNA-based, transgene-inserted vaccines for livestock, enabling rapid, variant-matched herd/flock immunization without whole pathogens and pursuing USDA approval for outbreak response.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Genvax Technologies.
